The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive in connection with a Rs 9 lakh bribery case.
In its charge sheet filed on August 18, the CBI had alleged that the bribe payment was made to Joint Drug Controller S Eswara Reddy after clearance from associate vice president of Biocon Biologics L Praveen Kumar, officials said.
The agency has also named Dinesh Dua, director at Synergy Network India Private Limited, who allegedly gave the bribe to Reddy, Guljit Sethi, an alleged conduit of Biocon Biologics, as well as assistant drug inspector Animesh Kumar in the charge sheet, they said.
The bribe was allegedly meant for favourably recommending the file of Insulin Aspart Injection to the Subject Expert Committee (SEC) meeting on May 18 for waiving the Phase 3 clinical trial, they said.
The sanction for prosecution against Reddy and other CDSCO officials is awaited, they said.
In a coordinated operation, the CBI had arrested all five accused.
Biocon Biologics is a subsidiary of Kiran Mazumdar Shaw-led Biocon. However, the company has denied the allegations of bribery.